ADB-INACA

ADB-INACA is classified as a synthetic cannabinoid. Synthetic cannabinoids have been reported to cause psychoactive effects similar to delta-9-tetrahydrocannabinol (THC). Synthetic cannabinoids have caused adverse events, including deaths, as described in the literature. Little information is currently known about the activity, potency, and/or toxicity of ADB-INACA. It is suspected that ADB-INACA is a precursor, specifically to other synthetic cannabinoids like ADB-BINACA (ADB-BUTINACA), and therefore overall potency is expected to be low. New synthetic cannabinoids continue to emerge among the recreation drug supply internationally, seemingly as replacements after a synthetic cannabinoid class-wide ban implemented by China in July 2021 which included most traditional indole and indazole structural scaffolds. Many of these new synthetic cannabinoid analogues are unstudied with pharmacological and human effects undetermined. Currently, ADB-INACA is not a scheduled substance in the United States.

Class:

Cannabinoid

Appearance:

White Solid Material on White Paper

Formula:

C14H18N4O2

MW:

274.3

[M+]:

274

[M+H]+:

275.1503

IUPAC:

N-(1-carbamoyl-2,2-dimethyl-propyl)-1H-indazole-3-carboxamide

Report Date:

December 14, 2022